Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2024 for E.L.F. Beauty, Inc. (NYSE: ELF), a multi-brand beauty company offering inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skincare. The company operates as a single reportable segment with brands including e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People, and Keys Soulcare. The filing reflects the integration of the Naturium acquisition completed in October 2023.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Net Sales | $301.1 million | $215.5 million | $625.6 million | $431.8 million |
| Gross Profit | $214.1 million | $152.4 million | $445.3 million | $304.9 million |
| Gross Margin | 71.1% | 70.7% | 71.2% | 70.6% |
| Operating Income | $27.9 million | $40.2 million | $78.6 million | $100.8 million |
| Net Income | $19.0 million | $33.3 million | $66.6 million | $86.2 million |
| Diluted EPS | $0.33 | $0.58 | $1.14 | $1.50 |
| Cash & Equivalents | $96.8 million (as of Sept 30, 2024) | |||
| Total Debt | $257.5 million (as of Sept 30, 2024) | |||
| Operating Cash Flow | N/A | $12.4 million | $51.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 40% year-over-year (YoY) for the quarter and 45% YoY for the six-month period. Growth was driven by a 30% increase in retailer channel sales and a 112% increase in e-commerce sales for the quarter.
- Profitability Compression: While gross margin expanded slightly (40 basis points for the quarter), operating income declined 30% YoY for the quarter ($27.9M vs $40.2M) and 22% YoY for the six months. This was primarily due to a significant increase in Selling, General, and Administrative (SG&A) expenses.
- SG&A Expansion: SG&A expenses rose 66% YoY for the quarter ($186.1M vs $112.2M), increasing from 52% to 62% of net sales. Drivers included a $26.9M increase in marketing/digital spend, $18.7M in higher compensation (partially due to accelerated stock-based compensation vesting), and increased operational costs.
- Debt Levels: Total debt increased significantly to $257.5 million from $64.0 million in the prior year, reflecting the $115 million incremental term loan and revolving credit facility draws used to fund the Naturium acquisition.
- Cash Flow: Operating cash flow decreased to $12.4 million for the six months ended Sept 30, 2024, compared to $51.3 million in the prior year, largely due to a $114.2 million increase in working capital (inventory, receivables, and prepaid expenses).
Guidance, Outlook, and Risks
Management Commentary: Management attributes revenue growth to strength in both retailer and e-commerce channels, driven by higher unit volume and favorable price/mix. The company notes that the increase in SG&A is strategic, focusing on marketing, digital capabilities, and retail expansion. The company expects to fund ongoing needs through existing cash, operating cash flow, and its revolving credit facility.
Capital Allocation: On August 27, 2024, the Board authorized a new $500 million share repurchase program. The previous $25 million program was exhausted in the quarter with the repurchase of 108,753 shares for $17.1 million. No shares were repurchased under the new program during the quarter.
Key Risks and Contingencies:
- Supply Chain & Geopolitics: Significant reliance on third-party manufacturers in China exposes the company to trade tensions, labor costs, and shipping disruptions (e.g., Red Sea conflicts).
- Regulatory Compliance: The company faces evolving regulations, including the Modernization of Cosmetics Regulation Act (MoCRA) in the U.S. and data privacy laws (GDPR, CCPA) internationally.
- Competition: The beauty industry is highly competitive with low barriers to entry for new brands and intense pressure on pricing and shelf space.
- Acquisition Integration: Risks associated with integrating Naturium, including potential failure to realize expected synergies or revenue growth.
Investor Verification Checklist
- Verify the sustainability of the 40% revenue growth rate given the 66% increase in SG&A expenses.
- Monitor the impact of the $257.5 million debt load on future interest expenses and leverage ratios, especially with variable interest rates.
- Assess the effectiveness of the new $500 million share repurchase program in offsetting dilution from stock-based compensation.
- Track working capital trends, specifically inventory levels, to ensure they align with sales velocity and do not lead to future write-downs.
- Review the integration progress of the Naturium acquisition and its contribution to the overall gross margin profile.